天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國籍:中國
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11973
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

PDK1-IN-RS2 1643958-89-7
Eptinezumab 1644539-04-7
HTL14242 1644645-32-8
ACT-660602 1646267-59-5
Tomuzotuximab 1646321-00-7
FD-IN-1 1646682-14-5
Gimsilumab 1648796-29-5
(Rac)-MEM 1003 165187-25-7
Fremanezumab 1655501-53-3
CRT-0105950 1661845-86-8
Flotetuzumab 1664355-28-5
Timigutuzumab 1665274-14-5
CT-2584 166981-13-1
Relatlimab 1673516-98-7
TGP-377/421 16752-89-9
Fluoroethylnormemantine 1639210-26-6
Lupartumab 1640971-88-5
TASP0390325 1642187-96-9
Leramistat 1642602-54-7
Zilovertamab 1643432-38-5
SLMP53-1 1643469-17-3
Frovocimab 1643672-70-1
Nav1.8-IN-4 1620846-16-3
Selicrelumab 1622140-49-1
Laprituximab 1622327-38-1
Naratuximab 1622327-39-2
Glycopyrronium tosylate 1624259-25-1
AC 7739 162705-22-8
JG-231 1627126-59-3
Rivabazumab 1627519-84-9
Nerelimomab 162774-06-3
CPL304110 1627826-19-0
Vobarilizumab 1628814-88-9
Itacnosertib 1628870-27-8
Suptavumab 1629615-23-1
Suvratoxumab 1629620-18-3
Ladiratuzumab 1629760-28-6
(R)-DNMDP 1630760-60-9
DA-6886 1645260-76-9
Dapson-13C12 1632119-29-9
Ranevetmab 1632282-27-9
DHODH-IN-17 16344-26-6
TDRL-551 1644626-43-6
Aprutumab 1634620-63-5
Tavolixizumab 1635395-25-3
RS1-PDK1 inhibitor 1643958-85-3
URAT1 inhibitor 7 1632002-28-8
GS-626510 1637770-13-8
DI-82 1638148-50-1
Dalzanemdor 1629853-48-0
Otilimab 1638332-55-4
Navicixizumab 1638338-43-8
VU0453379 1638646-27-1
Vonlerolizumab 1638935-72-4
MAO-B-IN-8 1638956-60-1
ALDH2 modulator 1 1629615-99-1
Ibiglustat succinate 1629063-80-4
KZR-504 1629052-78-3
GBT1118 1628799-51-8
FGFR4-IN-5 1628793-01-0
MLK-IN-1 1627729-62-7
TAK-020 1627603-21-7
Gü2602 1627094-88-5
(Rac)-Telinavir 162679-88-1
ABI-1968 1626364-18-8
hTYR/AbTYR-IN-1 1625821-37-5
Azido-PEG3-C6-Cl 1625717-44-3
Zectivimod 1623066-63-6
GPR81 agonist 1 1620992-67-7
TL4-12 1620820-12-3
GNE-8505 1620573-48-9
3-(Piperidin-4-yl)benzo[d]oxazol-2(3H)-one hydrochloride 162045-54-7
L-372662 162045-26-3
Honokiol DCA 1620160-42-0
Talastine 16188-61-7
Elsubrutinib 1643570-24-4
PW0464 1643462-93-4
Delmetacin 16401-80-2
Enrasentan 167256-08-8
AGN 192870 166977-57-7
Parthenosin 166196-16-3
(Rac)-Naxifylline 166181-76-6
BrBzGCp2 166038-00-2
Inotuzumab 1660159-36-3
NDB 1660153-08-1
(R)-AZD 9639 1646857-28-4
BTA-9881 1646857-24-0
Talviraline 163451-80-7
Ralaniten triacetate 1637573-04-6
Cipepofol 1637741-58-2
Osimertinib-d6 1638281-44-3
BDBM50597431 1629853-49-1
Karavilagenin F 1639024-15-9
UniPR129 1639159-47-9
Fluoroethylnormemantine hydrochloride 1639210-25-5
Isolupalbigenin 162616-70-8
Clivatuzumab 1622075-09-5
UCM-13207 1621536-10-4
pan-HER-IN-2 1639040-95-1
ZEN-3694 1643947-30-1
87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.